Reaction Details |
| Report a problem with these data |
Target | Nuclear factor erythroid 2-related factor 2 |
---|
Ligand | BDBM50200468 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1622116 (CHEMBL3864468) |
---|
IC50 | 875±n/a nM |
---|
Citation | Jiang, ZY; Lu, MC; You, QD Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions. J Med Chem59:10837-10858 (2016) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Nuclear factor erythroid 2-related factor 2 |
---|
Name: | Nuclear factor erythroid 2-related factor 2 |
Synonyms: | HEBP1 | Kelch-like ECH-associated protein 1 | NF-E2-related factor 2 | NF2L2_HUMAN | NFE2-related factor 2 | NFE2L2 | NRF2 | Nuclear factor erythroid 2-related factor 2 | Nuclear factor, erythroid derived 2, like 2 |
Type: | PROTEIN |
Mol. Mass.: | 67786.89 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_107924 |
Residue: | 605 |
Sequence: | MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQE
QLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCM
QLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGM
QQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVG
NCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMP
SPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHS
VESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDA
QCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVD
FNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLL
KEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKP
DVKKN
|
|
|
BDBM50200468 |
---|
n/a |
---|
Name | BDBM50200468 |
Synonyms: | CHEMBL3919787 |
Type | Small organic molecule |
Emp. Form. | C33H52N8O15 |
Mol. Mass. | 800.8106 |
SMILES | CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(C)=O)[C@@H](C)O)C(O)=O |r| |
Structure |
|